Case report: Neuromuscular block induced by rocuronium following sugammadex administration

被引:3
作者
Askin, Tugba [1 ]
Unver, Suheyla [1 ]
Oguz, Deniz [1 ]
Kutay, Kubra [1 ]
机构
[1] Dr Abdurrahman Yurtaslan Ankara Oncol Training &, Ankara, Turkey
关键词
Sugammadex; Rocuronium; Neuromuscular block; REVERSAL;
D O I
10.1016/j.jclinane.2016.11.004
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
We present a case in which rocuronium was applied for muscle relaxation following the administration of sugammadex. An emergency surgery under general anesthesia was planned for a 43-year-old male patient due to an L1 vertebral corpus and right tibia-fibula shaft fracture. Anesthesia was induced with fentanyl, propofol and lidocaine. After applying only 30 mg of the total induction dose of rocuronium, it was learned that the neurological examination should be controlled again from the surgeon because of the controversial of the neurological deficit. As a result, patient awakened from anesthesia. We administered 2 mg/kg sugammadex and spontaneous breathing of patient returned immediately. The patient became conscious and orientated immediately afterwards. The neurological examination of the lower extremities was performed. The patient was anesthetized once again and 0.6 mg/kg rocuronium was given in order to gain neoromuscular block approximately 10 min after sugammadex administration. 2 min later, the patient was smoothly intubated. Neuromuscular monitorization was not used because of emergency. We administered 2 mg/kg sugammadex at the end of the procedure and the patient was extubated. The most suitable time for the re-establishment of rocuronium following sugammadex is currently unclear. This case showed that neuromuscular block can be effectively re-induced by rocuronium following the reversal of rocuronium-induced neuromuscular block with sugammadex. In this case, we consider that the ability to effectively reuse normal induction doses of rocuronium is an important clinical observation. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:166 / 167
页数:2
相关论文
共 6 条
  • [1] BOM A, 2005, EUR J ANESTHESIO S34, V22, P120
  • [2] Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: a modelling-based pilot study
    Cammu, G.
    de Kam, P. -J.
    De Graeve, K.
    van den Heuvel, M.
    Suy, K.
    Morias, K.
    Foubert, L.
    Grobara, P.
    Peeters, P.
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2010, 105 (04) : 487 - 492
  • [3] Non-steroidal neuromuscular blocking agents to re-establish paralysis after reversal of rocuronium-induced neuromuscular block with sugammadex
    de Boer, Hans D.
    Driessen, Jacques J.
    van Egmond, Jan
    Booij, Leo H. D. J.
    [J]. CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2008, 55 (02): : 124 - 125
  • [4] Intubating conditions and side effects of propofol, remifentanil and sevoflurane compared with propofol, remifentanil and rocuronium: a randomised, prospective, clinical trial
    Mencke, Thomas
    Jacobs, Refa Maria
    Machmueller, Susann
    Sauer, Martin
    Heidecke, Christine
    Kallert, Anja
    Pau, Hans Wilhelm
    Noeldge-Schomburg, Gabriele
    Ovari, Attila
    [J]. BMC ANESTHESIOLOGY, 2014, 14
  • [5] Sugammadex in clinical practice
    Mirakhur, R. K.
    [J]. ANAESTHESIA, 2009, 64 : 45 - 54
  • [6] Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study - Efficacy, safety, and pharmacokinetics
    Sparr, Harald J.
    Vermeyen, Karel M.
    Beaufort, Anton M.
    Rietbergen, Henk
    Proost, Johannes H.
    Saldien, Vera
    Velik-Salchner, Corinna
    Wierda, J. Mark K. H.
    [J]. ANESTHESIOLOGY, 2007, 106 (05) : 935 - 943